These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 36661684

  • 1. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
    Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J.
    Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684
    [Abstract] [Full Text] [Related]

  • 2. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J, Liang Y, Gu JJ, Huang Y, Wang B.
    Front Genet; 2022 Dec 28; 13():991162. PubMed ID: 36353118
    [Abstract] [Full Text] [Related]

  • 3. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.
    Peng YL, Dong YF, Guo LL, Li MY, Liao H, Li RS.
    PLoS One; 2023 Dec 28; 18(8):e0289552. PubMed ID: 37535570
    [Abstract] [Full Text] [Related]

  • 4. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs.
    Gao Y, Ren J, Chen K, Guan G.
    J Gastrointest Oncol; 2024 Feb 29; 15(1):203-219. PubMed ID: 38482248
    [Abstract] [Full Text] [Related]

  • 5. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
    Dai YY, Gao YP, Chen LX, Liu JS, Zeng C, Zhou JD, Wu HL.
    Front Genet; 2022 Feb 29; 13():930446. PubMed ID: 36110218
    [Abstract] [Full Text] [Related]

  • 6. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S, Bai H, Fei S, Miao B.
    Biochem Genet; 2024 Jun 29; 62(3):2332-2351. PubMed ID: 37898914
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X.
    Front Genet; 2022 Jun 29; 13():929035. PubMed ID: 36081998
    [Abstract] [Full Text] [Related]

  • 8. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
    Li Y, Zhao K, Wu R, Wang J, Wang Q, Xiong Q, Xie F, Lei H, Feng P.
    J Gastrointest Oncol; 2023 Jun 30; 14(3):1392-1411. PubMed ID: 37435203
    [Abstract] [Full Text] [Related]

  • 9. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.
    World J Gastroenterol; 2019 Jan 14; 25(2):220-232. PubMed ID: 30670911
    [Abstract] [Full Text] [Related]

  • 10. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
    Li R, Liu X, Deng K, Wang X.
    BMC Med Genomics; 2023 Aug 01; 16(1):179. PubMed ID: 37528384
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
    Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S.
    Front Genet; 2022 Aug 01; 13():906496. PubMed ID: 35938009
    [Abstract] [Full Text] [Related]

  • 12. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J, Huang Z, Lin H, Cheng W, Lai J, Li J.
    BMC Cancer; 2022 Nov 04; 22(1):1132. PubMed ID: 36333719
    [Abstract] [Full Text] [Related]

  • 13. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
    Zhao B, Fang F, Liao Y, Chen Y, Wang F, Ma Y, Wei C, Zhao J, Ji H, Wang D, Tang D.
    BMC Bioinformatics; 2023 Mar 19; 24(1):100. PubMed ID: 36935487
    [Abstract] [Full Text] [Related]

  • 14. A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.
    Liu Y, Jiang J.
    Cancer Biomark; 2023 Mar 19; 37(1):13-26. PubMed ID: 37005878
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y, Wei X, Han Q, Le J, Ma Y, Lin X, Xu Y, Liu N, Wang X, Kong X, Gu J, Tong Y, Wu H.
    BMC Cancer; 2021 Oct 30; 21(1):1165. PubMed ID: 34717566
    [Abstract] [Full Text] [Related]

  • 16. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q, Wang Y, Huang W.
    Int Immunopharmacol; 2021 Mar 30; 92():107333. PubMed ID: 33486322
    [Abstract] [Full Text] [Related]

  • 17. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J, Zhou C, Guo K, Li Q, Wang Z.
    J Cell Biochem; 2019 Jan 30; 120(1):213-223. PubMed ID: 30206981
    [Abstract] [Full Text] [Related]

  • 18. A Novel Cholesterol Metabolism-Related lncRNA Signature Predicts the Prognosis of Patients with Hepatocellular Carcinoma and Their Response to Immunotherapy.
    Lei H, Xiang T, Zhu H, Hu X.
    Front Biosci (Landmark Ed); 2024 Mar 22; 29(3):129. PubMed ID: 38538256
    [Abstract] [Full Text] [Related]

  • 19. N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma.
    Ming J, Wang C.
    Front Genet; 2022 Mar 22; 13():871899. PubMed ID: 35495133
    [Abstract] [Full Text] [Related]

  • 20. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ, Zhang J, Xu L, Liu FF.
    World J Gastroenterol; 2018 Aug 14; 24(30):3426-3439. PubMed ID: 30122881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.